Found 178 matching trials
Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
PHASE2Apatinib plus XELOX regime as Neoadjuvant Therapy in Locally Advanced Gastr...
Location
ZhongShan hospital FuDan university
RC48 Combined With Adebrelimab, Apatinib and S-1 as Neoadjuvant Therapy in Locally Advanced Gastric Cancer
PHASE2This study is a prospective, open-label, phase II clinical trial that aims ...
Location
Multiple Locations
Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer
PHASE2This is a single-arm, phase II study aiming to evaluate the feasibility and...
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Surgical Conversion of Candonilimab (AK104) Plus Paclitaxel, S-1 and Apatinib for Unresectable Advanced G/GEJ Cancer
PHASE2This is a prospective, single-arm, open-label,single-center, phase II study...
Location
Tianjin Medical University Cancer Institute and Hospital
A Study of Paclitaxel Combined With Apatinib and Adebrelimab in Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE2To evaluate the initial efficacy and safety of paclitaxel for injection (al...
Location
The First Affiliated Hospital of Xiamen University
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
PHASE2Patients with locally advanced unresectable or metastatic hepatocellular ca...
Location
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Combination Neoadjuvant Chemotherapy With or Without Apatinib for HER2 Negative Breast Cancer
PHASE2RATIONALE:
The combination of anti-angiogenic targeted therapy with neoadj...
Status
Active Not Recruiting
Location
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function
PHASE1The primary objective of the study is to compare the pharmacokinetics of ap...
Location
Multiple Locations
Perioperative Treatment of Combined Radiotherapy With SOX, Apatinib and Camrelizumab for Oesophagogastric Cancer
PHASE2The study is being conducted to evaluate the efficacy, safety and tolerabil...
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
PHASE2This is a single arm, open-label, non-randomized and single-center phase II...